Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
22.57
-1.13 (-4.77%)
Jan 13, 2026, 4:00 PM EST - Market closed
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $4.17 billion as of January 13, 2026. Its market cap has decreased by -30.68% in one year.
Market Cap
4.17B
Enterprise Value
3.59B
1-Year Change
-30.68%
Ranking
Category
Stock Price
$22.57
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from $4.79B to $4.17B, a decrease of -12.90%. That is a compound annual growth rate of -2.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 4.17B | 3.82% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |